Intesa’s €35bn MPS bid faces deeper antitrust test over branches and Generali

Intesa Sanpaolo S.p.A. (Borsa Italiana: ISP) has entered a more demanding regulatory phase in its attempt to acquire Banca Monte dei Paschi di Siena S.p.A. (Borsa Italiana: BMPS), after Italy’s competition authority opened a formal investigation into the transaction on September 14. The cash-and-share offer was initially valued at approximately €30.6 billion when announced in June, although subsequent share-price movements have lifted its market value to roughly €35 billion. The Italian Competition Authority is examining whether the combination could weaken competition across numerous banking and insurance markets, including deposits, lending and insurance distribution. Intesa has already proposed substantial branch disposals as part of the structure, but the regulator is now assessing whether those remedies go far enough. The central issue is whether Intesa can preserve the scale and synergy benefits that make the acquisition attractive while accepting enough remedies to secure clearance.

Why has Italy’s competition authority opened a deeper review of Intesa’s MPS takeover?

The Italian Competition Authority said the significance of both banks and the breadth of the markets affected justified a formal investigation into the proposed concentration. Intesa is already Italy’s largest banking group, while Monte dei Paschi has become a materially larger strategic player after its own recent transactions. Combining the two would therefore affect not only national market shares but competitive conditions in individual provinces where customers have fewer banking alternatives.

The authority is examining several retail and commercial banking activities rather than focusing on a single product. Areas under scrutiny include deposits, lending to households and small businesses, and related financial services. Competition concerns can become particularly acute in banking because national market shares may understate concentration in provinces where a small number of institutions control most branches and customer relationships.

The investigation does not mean the transaction has been rejected. It means the authority believes the deal requires further examination before it can determine whether approval, remedies or prohibition is appropriate. For Intesa, the practical challenge is now to demonstrate that the transaction can proceed without materially reducing customer choice or weakening competitive pressure.

How does Intesa’s proposed disposal of MPS branches attempt to address antitrust concerns?

Branch disposals were built into the transaction from the beginning rather than added only after the latest regulatory intervention. Intesa signed an agreement with Unipol under which a banking business comprising the MPS brand, 635 branches and a significant portion of related central activities would be transferred as part of the broader transaction structure. The competition authority considers that disposal an integral part of its assessment of the acquisition.

The logic is straightforward. Removing hundreds of branches from the combined Intesa and MPS network reduces geographic overlap and creates or strengthens an alternative competitor in areas where the merger would otherwise produce excessive concentration. It also helps limit the increase in Intesa’s share of deposits, mortgages and small-business lending.

The difficulty is determining whether branch numbers alone solve the underlying competition problem. A divested network must have sufficient customers, employees, systems, products and financial capacity to remain competitive after separation. Regulators therefore examine not only how many branches are sold but whether the transferred business can function as a credible independent banking platform.

Why are deposits and small-business lending emerging as particular concerns for the regulator?

According to the latest competition assessment, potential concerns remain in around 20 provinces for deposit-taking activities and 17 provinces for lending to small and medium-sized businesses. Earlier analysis had also identified wider geographic overlap in household lending. These local-market issues matter because banking customers, particularly smaller companies and retail customers, often maintain relationships with institutions operating physically or commercially within their region.

Small businesses may be especially sensitive to consolidation because lending frequently depends on established relationships, local credit knowledge and access to branch networks. If a merger removes a major competing lender from a province, the remaining banks could face less pressure on pricing and service even if national banking competition remains strong.

For Intesa, this creates a trade-off between regulatory clearance and the economic benefits of combining overlapping franchises. Selling too few branches may fail to satisfy the authority, while selling too many could reduce the customer base and revenue synergies that support the transaction’s valuation. The eventual remedy package will therefore be an important indicator of how much strategic value remains after clearance.

Why has Generali become another antitrust issue in the Intesa and MPS transaction?

The review extends beyond traditional banking because Monte dei Paschi’s corporate structure also creates exposure to Italy’s insurance market. An Intesa acquisition of MPS would give the enlarged group an indirect interest of roughly 13% in Assicurazioni Generali, Italy’s largest insurer. Intesa itself competes in life insurance and wealth management, making the governance implications of that shareholding relevant to competition authorities.

The concern is not simply the financial value of the Generali stake. Regulators are examining whether governance rights, board representation or access to commercially sensitive information could weaken competition between Intesa and Generali in insurance and savings products. Even a minority investment can attract scrutiny if it creates influence over a significant competitor.

Intesa has sought to address these concerns, including commitments intended to limit influence over Generali. The authority must now decide whether structural or governance protections are sufficient to prevent coordination or information-sharing risks. That insurance dimension makes the review considerably more complex than a conventional branch-overlap exercise.

How has the value of Intesa’s offer for Monte dei Paschi changed since June?

When Intesa announced the offer on June 8, it valued Monte dei Paschi at approximately €30.6 billion based on Intesa’s June 5 share price. The consideration consists of 16 newly issued Intesa shares for every 10 MPS shares tendered, plus €1 in cash for each MPS share. Because most of the consideration is equity, the market value of the offer moves as Intesa’s share price changes.

At more recent prices, the transaction has been described as worth roughly €35 billion. That does not mean Intesa has formally increased the exchange ratio or cash component. It reflects the higher market value of the Intesa shares being offered relative to the reference price used when the bid was announced.

The distinction matters because MPS shareholders remain exposed to Intesa’s market price until the offer completes. A stronger Intesa share price increases the implied value of the bid, while a weaker price reduces it. The transaction is therefore economically different from an all-cash takeover where the headline price remains fixed regardless of market movements.

Why did Intesa shareholders strongly support the transaction despite its size?

Intesa shareholders approved the required capital increase on September 10 with almost 97% of votes represented supporting the proposal. The authorisation allows the board to issue up to 5.7 billion new ordinary shares in connection with the MPS offer. That approval removed one of the most important internal corporate conditions facing the transaction.

Management argues that the combination would create one of Europe’s largest banking groups, with more than 27 million customers and close to €2 trillion of customer financial assets by 2029. Intesa also expects the enlarged group to generate more than €16 billion of annual net income by that point while maintaining significant shareholder distributions.

The strategic rationale rests on scale, cost efficiencies, broader customer relationships and the ability to spread technology investment across a larger base. The shareholder vote indicates substantial support for that strategy. Regulatory approval, however, will determine how much of the planned operating overlap Intesa can actually retain.

How does Monte dei Paschi’s own acquisition strategy complicate Intesa’s takeover attempt?

Monte dei Paschi is not behaving like a passive takeover target. The bank has launched its own proposals involving Banco BPM and Banca Generali, creating an unusually complex consolidation contest in which the target of one acquisition is simultaneously pursuing other major transactions. MPS has said those offers remain valid even if Intesa ultimately gains control.

Monte dei Paschi estimates that its proposed transactions could generate approximately €1.8 billion of pre-tax benefits, including cost and revenue synergies. Shareholders are expected to vote on the strategy on October 29, adding another major decision point before Italy’s banking consolidation picture becomes clearer.

For Intesa, these moves create both strategic and timing risks. If MPS shareholders approve major acquisitions before Intesa completes its own offer, the asset profile Intesa ultimately acquires could become substantially different from the bank it originally targeted. Regulatory sequencing may therefore be almost as important as valuation.

What do current share prices suggest about market expectations for the Intesa and MPS battle?

Monte dei Paschi shares closed at €11.81 on September 15, up 1.5% for the session and close to the upper end of their 52-week range of approximately €6.84 to €12.08. The stock has remained elevated as investors assess Intesa’s offer alongside MPS’s own consolidation plans. Trading volumes have also been substantial, reflecting the number of possible outcomes still facing shareholders.

Intesa shares closed at €6.698 on September 15, down about 0.2% for the day after falling 1.8% in the previous session. The stock nevertheless remained near levels that make the equity component of the MPS offer more valuable than it was at announcement. Because Intesa is issuing a large number of new shares, investors must weigh the expected benefits of the acquisition against dilution and integration risk.

The market response does not resolve which strategic path will prevail. MPS shares reflect a mixture of takeover value, standalone prospects and potential value from its proposed Banco BPM and Banca Generali transactions. Intesa’s valuation meanwhile reflects the much larger group’s earnings outlook, capital returns and the financial consequences of absorbing MPS.

Could competition remedies materially reduce the financial logic of Intesa’s €35 billion bid?

The answer depends on the scale of any additional concessions. A manageable branch divestment programme may preserve most of the planned economics, especially if Intesa can still capture technology, funding and central-cost efficiencies. More extensive remedies involving customers, insurance relationships or strategically important regions could reduce the value available from integration.

The transaction is large enough that even modest changes in expected synergies can influence returns on invested capital. Intesa must also integrate an institution with its own systems, workforce, customers and strategic holdings while maintaining capital strength and shareholder distributions. Additional regulatory conditions could increase both execution complexity and the time required to capture benefits.

The key issue is therefore not simply whether the acquisition receives approval. Investors need to know the conditions attached to that approval and whether the resulting business still resembles the transaction originally presented in June. Clearance with heavy structural remedies can produce a very different economic outcome from clearance with limited behavioural commitments.

What are the next milestones for Intesa’s attempted acquisition of Monte dei Paschi?

The competition investigation is now one of the most important regulatory steps. Intesa must respond to the authority’s concerns and may need to refine its remedy package before the offer can proceed. Other supervisory and transaction conditions also remain relevant before the tender process can move to completion.

Separately, Monte dei Paschi shareholders are due to consider the bank’s Banco BPM and Banca Generali proposals on October 29. Those votes could materially change the strategic landscape before Intesa reaches the final stages of its own transaction. Timing therefore remains unusually important because several interdependent deals are advancing simultaneously.

Intesa originally targeted completion by the end of 2026. That remains possible if regulatory approvals arrive and the transaction timetable stays on track, but the formal antitrust investigation has increased the importance of remedies and sequencing. The next decisive evidence will be whether Italy’s competition authority accepts the planned branch and governance measures or requires a substantially larger restructuring of the deal.

Key takeaways on the antitrust test facing Intesa’s bid for Monte dei Paschi

• Italy’s competition authority has opened a formal investigation into Intesa Sanpaolo’s proposed acquisition of Monte dei Paschi.
• The transaction was initially valued at approximately €30.6 billion and is now worth around €35 billion at more recent Intesa share prices.
• Intesa is offering 16 new shares for every 10 MPS shares plus €1 in cash for each MPS share tendered.
• The regulator is examining competition across banking and insurance markets at both local and national levels.
• Potential concerns include deposit markets in around 20 provinces and small-business lending in 17 provinces.
• Intesa’s planned remedy package includes the transfer of an MPS banking business containing 635 branches to Unipol.
• The enlarged group’s indirect exposure to Generali has introduced additional insurance and governance concerns.
• Intesa shareholders approved the required capital increase with almost 97% support on September 10.
• MPS is simultaneously pursuing Banco BPM and Banca Generali transactions, with a shareholder vote expected on October 29.
• The decisive issue is no longer only whether the acquisition clears, but whether required remedies leave enough synergies and strategic value to justify the transaction.